Gregory Fraser
Stock Analyst at Truist Securities
(2.65)
# 2,009
Out of 5,113 analysts
38
Total ratings
55.56%
Success rate
16.48%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Hold | $77 → $90 | $79.51 | +13.19% | 11 | Oct 9, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $220 → $230 | $165.41 | +39.05% | 1 | Mar 6, 2025 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $5.66 | +23.67% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $200 → $160 | $1.27 | +12,498.43% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $2.07 | +334.78% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $13.95 | -49.82% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $45.85 | -36.75% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $12.58 | +655.17% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $4.80 | +275.00% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $25.45 | +57.17% | 2 | May 26, 2023 |
ANI Pharmaceuticals
Oct 9, 2025
Maintains: Hold
Price Target: $77 → $90
Current: $79.51
Upside: +13.19%
Jazz Pharmaceuticals
Mar 6, 2025
Maintains: Buy
Price Target: $220 → $230
Current: $165.41
Upside: +39.05%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $5.66
Upside: +23.67%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $200 → $160
Current: $1.27
Upside: +12,498.43%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $2.07
Upside: +334.78%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $13.95
Upside: -49.82%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $45.85
Upside: -36.75%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $12.58
Upside: +655.17%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $4.80
Upside: +275.00%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $25.45
Upside: +57.17%